Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

NCT06760039 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: R-CMOP Regimen
DRUG: R-CHOP Regimen

Sponsor

Sun Yat-sen University